Diclofenac delays micropore closure following microneedle treatment in human subjects

Journal of Controlled Release

Volumn 163, Issue 2, 2012, Pages 220-229

  Brogden, Nicole K ^a   Milewski, Mikolaj ^a   Ghosh, Priyanka ^a   Hardi, Lucia ^b   Crofford, Leslie J ^b   Stinchcomb, Audra L ^a,c,d  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c AllTranz Inc   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Clinical; Diclofenac; Human; Microneedle; Micropore; Transdermal

Indexed keywords

CLINICAL; DICLOFENAC; HUMAN; MICRONEEDLES; MICROPORES; TRANSDERMAL;

DRUG DELIVERY; NEEDLES; SKIN; SODIUM;

MICROPOROSITY;

DICLOFENAC; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; COLORIMETRY; DRUG FORMULATION; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL DEVICE; MICRONEEDLE; MICROPORE; NEEDLE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SKIN IRRITATION; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DIELECTRIC SPECTROSCOPY; FEMALE; HUMANS; MALE; MICROINJECTIONS; MIDDLE AGED; NEEDLES; POROSITY; SKIN; TRANSDERMAL PATCH; YOUNG ADULT;

EID: 84866673733     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.08.015     Document Type: Article

References (47)

1. A. Naik, Y.N. Kalia, and R.H. Guy Transdermal drug delivery: overcoming the skin's barrier function Pharm. Sci. Technol. Today 3 9 2000 318 326
2. M.R. Prausnitz, and R. Langer Transdermal drug delivery Nat. Biotechnol. 26 11 Nov 2008 1261 1268
3. M.R. Prausnitz Microneedles for transdermal drug delivery Adv. Drug Deliv. Rev. 56 5 2004 581 587 (Pubitemid 38326934)
4. M.I. Haq, E. Smith, D.N. John, M. Kalavala, C. Edwards, A. Anstey, A. Morrissey, and J.C. Birchall Clinical administration of microneedles: skin puncture, pain and sensation Biomed. Microdevices 11 1 Feb 2009 35 47
5. S. Kaushik, A.H. Hord, D.D. Denson, D.V. McAllister, S. Smitra, M.G. Allen, and M.R. Prausnitz Lack of pain associated with microfabricated microneedles Anesth. Analg. 92 2 Feb 2001 502 504 (Pubitemid 32127644)
6. J.A. Mikszta, J.B. Alarcon, J.M. Brittingham, D.E. Sutter, R.J. Pettis, and N.G. Harvey Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery Nat. Med. 8 4 Apr 2002 415 419 (Pubitemid 34407039)
7. W.H. Smart, and K. Subramanian The use of silicon microfabrication technology in painless blood glucose monitoring Diabetes Technol. Ther. 2 4 Winter 2000 549 559 (Pubitemid 32173118)
8. Vaccine Shoppe http://www.vaccineshoppe.com/static/FluID2/fluid-video- desktop.html Accessed March 7, 2012
9. D.P. Wermeling, S.L. Banks, D.A. Hudson, H.S. Gill, J. Gupta, M.R. Prausnitz, and A.L. Stinchcomb Microneedles permit transdermal delivery of a skin-impermeant medication to humans Proc. Natl. Acad. Sci. U. S. A. 105 6 2008 2058 2063 (Pubitemid 351439464)
10. P.E. Daddona, J.A. Matriano, J. Mandema, and Y.F. Maa Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis Pharm. Res. 28 1 Jan 2011 159 165
11. M. Milewski, N.K. Brogden, and A.L. Stinchcomb Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin Expert Opin. Drug Deliv. 7 5 May 2010 617 629
12. 3M Microneedle Technology http://solutions.3m.com/wps/portal/3M/en-WW/ DrugDeliverySystems/DDSD/technology-solutions/transdermal-technologies/ microstructured-transdermal-systems/ Accessed March 27, 2011
13. S. Bal, A.C. Kruithof, H. Liebl, M. Tomerius, J. Bouwstra, J. Lademann, and M. Meinke In vivo visualization of microneedle conduits in human skin using laser scanning microscopy Laser Phys. Lett. 7 3 2010 242 246
14. J. Enfield, M.L. O'Connell, K. Lawlor, E. Jonathan, C. O'Mahony, and M. Leahy In-vivo dynamic characterization of microneedle skin penetration using optical coherence tomography J. Biomed. Opt. 15 4 Jul-Aug 2010 046001
15. S.L. Banks, K.S. Paudel, N.K. Brogden, C.D. Loftin, and A.L. Stinchcomb Diclofenac enables prolonged delivery of naltrexone through microneedle-treated skin Pharm. Res. 28 5 May 2011 1211 1219
16. G.L. Flynn Cutaneous and transdermal delivery: processes and systems of delivery G.S. Banker, C.T. Rhodes, Modern Pharmaceutics 2nd ed. 1990 Marcel Dekker New York 239 298
17. G. Grubauer, P.M. Elias, and K.R. Feingold Transepidermal water loss: the signal for recovery of barrier structure and function J. Lipid Res. 30 3 Mar 1989 323 333 (Pubitemid 19082061)
18. A.H. Lackermeier, E.T. McAdams, G.P. Moss, and A.D. Woolfson In vivo ac impedance spectroscopy of human skin. Theory and problems in monitoring of passive percutaneous drug delivery Ann. N. Y. Acad. Sci. 873 1999 197 213 (Pubitemid 29263667)
19. H. Tagami, M. Ohi, K. Iwatsuki, Y. Kanamaru, M. Yamada, and B. Ichijo Evaluation of the skin surface hydration in vivo by electrical measurement J. Invest. Dermatol. 75 6 Dec 1980 500 507 (Pubitemid 11210710)
20. T. Yamamoto, and Y. Yamamoto Electrical properties of the epidermal stratum corneum Med. Biol. Eng. 14 2 Mar 1976 151 158
21. Y.N. Kalia, and R.H. Guy The electrical characteristics of human skin in vivo Pharm. Res. 12 11 Nov 1995 1605 1613 (Pubitemid 26004683)
22. P. Karande, A. Jain, and S. Mitragotri Relationships between skin's electrical impedance and permeability in the presence of chemical enhancers J. Control. Release 110 2 2006 307 313 (Pubitemid 41827484)
23. R. Kohli, W.I. Archer, J.M.C. Roberts, A.J. Cochran, and A. Li Wan Po Impedance measurements for the non-invasive monitoring of skin hydration: a reassessment Int. J. Pharm. 26 1985 275 287 (Pubitemid 16228626)
24. C. Curdy, A. Naik, Y.N. Kalia, I. Alberti, and R.H. Guy Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo Int. J. Pharm. 271 1-2 2004 251 256 (Pubitemid 38210103)
25. E. Kawai, J. Nakanishi, N. Kumazawa, K. Ozawa, and M. Denda Skin surface electric potential as an indicator of skin condition: a new, non-invasive method to evaluate epidermal condition Exp. Dermatol. 17 8 Aug 2008 688 692 (Pubitemid 352044362)
26. E. White, and A. Bunge Reporting Skin Resistance and Impedance Paper presented at: Barrier Function of Mammalian Skin Gordon Research Conference 2009 Waterville Valley, NH
27. J. Gupta, H.S. Gill, S.N. Andrews, and M.R. Prausnitz Kinetics of skin resealing after insertion of microneedles in human subjects J. Control. Release 154 2 Sept 5 2011 148 155
28. M. Milewski, Microneedle-assisted transdermal delivery of naltrexone species: in vitro permeation and in vivo pharmacokientic studies. Lexington, KY, University of Kentucky Doctoral thesis; 2011.
29. A. Fullerton, T. Fischer, A. Lahti, K.P. Wilhelm, H. Takiwaki, and J. Serup Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis Contact Dermatitis 35 1 Jul 1996 1 10
30. C. Curdy, Y.N. Kalia, and R.H. Guy Post-iontophoresis recovery of human skin impedance in vivo Eur. J. Pharm. Biopharm. 53 1 Jan 2002 15 21 (Pubitemid 34036993)
31. J. Gupta, and M.R. Prausnitz Recovery of skin barrier properties after sonication in human subjects Ultrasound Med. Biol. 35 8 Aug 2009 1405 1408
32. P.K. Kiptoo, K.S. Paudel, D.C. Hammell, M.O. Hamad, P.A. Crooks, and A.L. Stinchcomb In vivo evaluation of a transdermal codrug of 6-beta-naltrexol linked to hydroxybupropion in hairless guinea pigs Eur. J. Pharm. Sci. 33 4-5 2008 371 379
33. E. Schnetz, T.L. Diepgen, P. Elsner, P.J. Frosch, A.J. Klotz, J. Kresken, O. Kuss, H. Merk, H.J. Schwanitz, W. Wigger-Alberti, and M. Fartasch Multicentre study for the development of an in vivo model to evaluate the influence of topical formulations on irritation Contact Dermatitis 42 6 Jun 2000 336 343 (Pubitemid 30333242)
34. M.B. Brown, and S.A. Jones Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin J. Eur. Acad. Dermatol. Venereol. 19 3 May 2005 308 318 (Pubitemid 40691707)
35. Micromedex® 2.0 http://www.thomsonhc.com/micromedex2/librarian/ 2011 Accessed March 7, 2011
36. T. Mauro, W.M. Holleran, S. Grayson, W.N. Gao, M.Q. Man, E. Kriehuber, M. Behne, K.R. Feingold, and P.M. Elias Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing Arch. Dermatol. Res. 290 4 Apr 1998 215 222 (Pubitemid 28230774)
37. R.O. Potts, and R.H. Guy A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity Pharm. Res. 12 11 Nov 1995 1628 1633 (Pubitemid 26004686)
38. R.H. Guy, and J. Hadgraft Physicochemical aspects of percutaneous penetration and its enhancement Pharm. Res. 5 12 Dec 1988 753 758 (Pubitemid 19060803)
39. R.O. Potts, and R.H. Guy Predicting skin permeability Pharm. Res. 9 5 May 1992 663 669
40. G. Smith, S.H. Ibbotson, M.M. Comrie, R.S. Dawe, A. Bryden, J. Ferguson, and C.R. Wolf Ref Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo Br. J. Dermatol. 155 2 Aug 2006 275 281 (Pubitemid 44050559)
41. PharmaDerm. Solaraze® gel package insert.2009.
42. K. Muller-Decker, G. Reinerth, P. Krieg, R. Zimmermann, H. Heise, C. Bayer, F. Marks, and G. Fürstenberger Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin Int. J. Cancer 82 5 1999 648 656 (Pubitemid 29356962)
43. D. Bucks, and H. Maibach Percutaneous Absorption 1999 Marcel Dekker, Inc. New York
44. C.L. Swadley, Investigation of Endocannabinoid System Modulators for Percutaneous Drug Delivery. Lexington, KY, University of Kentucky Doctoral thesis; 2011.
45. F. Andersen, K. Hedegaard, A. Fullerton, C. Bindslev-Jensen, and K.E. Andersen Comparison of the response to topical irritants in hairless guinea pigs and human volunteers J. Toxicol.-Cutan. Ocul. Toxicol. 24 2005 31 43 (Pubitemid 40922985)
46. R.F. Donnelly, T.R. Singh, M.M. Tunney, D.I. Morrow, P.A. McCarron, C. O'Mahony, and A.D. Woolfson Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro Pharm. Res. 26 11 Nov 2009 2513 2522
47. P. Ghosh, R.R. Pinninti, D.M. Lee, D.C. Hammell, K.S. Paudel, K.B. Kim, and A.L. Stinchcomb Microneedle enhanced transdermal delivery using a codrug approach Abstract presented at: American Association of Pharmaceutical Scientists, Annual meeting 2011 Washington D.C.